Results from the last call for proposals to GLOBVAC
The GLOBVAC Programme Board received a total of 50 applications by the 19 April, 2012 deadline. The call invited research proposals within the four thematic areas of the GLOBVAC Programme:
1. Vaccine and vaccination research;
2. Health systems and health policy research;
3. Innovation in technology and methods
4. Implementation research
The Programme Board decided to fund the following projects:
Researcher projects/young scientist grants approved for funding:
| Project no. | Title | Institution |
| 220554 | Combining indoor residual spraying and long-lasting insecticidal nets for preventing malaria: Cluster randomized trial in Ethiopia | University of Bergen |
| 220608 | Advocacy and policy change for health equity in low-income countries | University of Oslo |
| 220642 | Generation of DNA vaccines specifically targeting cross-presenting DCs, and evaluation of their efficacy against Tuberculosis. | Oslo University Hospital HF |
| 220807 | Community-based organizing against HIV and for rights among same-sex attracted men in Dar es Salaam, Tanzania | University of Oslo |
| 220836 | Creating efficient vaccine candidates against Tuberculosis using mutant Mycobacterium smegmatis | Norwegian University of Science and Technology |
| 220847 | A novel targeted mucosal vaccine | University of Oslo |
| 220895 | A pilot study to promote child health in the first year of life | University of Oslo |
Innovation project in the Industrial Sector approved for funding. Note, funding is conditional.
| Project no. | Title | Institution |
| 220762 | Towards Eradication of HIV-1: Therapeutic Vaccination with the peptide-based candidate Vacc-4x | Bionor Immuno AS |
Researcher projects/young scientist grants approved for funding with reduced amount/contingent on satisfactory revision:
| Project no. | Title | Institution |
| 220603 | Supporting informed healthcare choices in low-income countries | Norwegian Knowledge Centre for the Health Services |
| 220622 | Treatment of hepatitis B in resource-limited settings - a pilot program in Yemen and East Africa | Oslo University Hospital HF |
| 220670 | Improved childhood vaccination and preparedness against seasonal and pandemic influenza: prospects for cellular immunity | Norwegian Institute for Public Health |
| 220757 | The useful life of bednets for malaria control in Tanzania: Attrition, Bioefficacy, Chemistry, Durability and insecticide Resistance | Norwegian University of Life Sciences |
| 220829 | Meningococcal vaccines for Africa: Impact of MenAfriVac on serogroup A transmission and clinical evaluation of a new protein-based vaccine |
Norwegian Institute for Public Health |
| 220851 | Skilled attendants at Every birth: Essential requirements for the delivery of basic emergency obstetric care | Norwegian Knowledge Centre for the Health Services |
| 220873 | Communicate to vaccinate (COMMVAC) 2: Implementing communication interventions to improve childhood vaccination uptake in LICs | Norwegian Knowledge Centre for the Health Services |
| 220887 | SeeTheChild - Mental child health in Uganda | University in Bergen |
| 220893 | Evaluating interventions in antenatal care to identify and assist victims of gender based violence in Nepal and Sri Lanka | Norwegian University of Science and Technology |
| 220901 | Genetically engineered N. lactamica as a vaccine delivery agent | Oslo University Hospital HF |
Please note: All applicants will receive a letter from the Research Council of Norway informing them about the GLOBVAC Programme Board’s decision. We kindly ask all applicants to refrain from contacting the Research Council until they have received the letters and assessments on “My RCN Web”.
- Published:
- 14.06.2012
